WallStreetZenWallStreetZen

AnalystsAndrea Tan
Andrea Tan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4251 out of 4554 analysts
Average Return
-9.39%
Win Rate
30%7 out of 23
Risk vs Reward
Poor
Good

Andrea Tan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iovance Biotherapeutics IncIOVA
+113.48%$5.49$11.72
2023-11-19 -
2024-04-18
Strong Buy
Fate Therapeutics IncFATE
+79.03%$14.21$2.98
2022-12-14 -
2023-12-14
Strong Sell
Insmed IncINSM
+68.24%$17.79$29.93
2023-01-08 -
2024-01-08
Strong Buy
Krystal Biotech IncKRYS
+56.49%$104.78$163.97
2023-11-19 -
2024-04-18
Strong Buy
Verve Therapeutics IncVERV
+26.64%$19.52$14.32
2022-12-14 -
2023-12-14
Strong Sell

Andrea Tan Analyst Color

Get additional color on Andrea Tan's coverage of popular stocks

Andrea Tan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Sagimet Biosciences IncSGMT
3Strong Buy$27.00+580.10%Maintains
24 days ago
Iovance Biotherapeutics IncIOVA
4Strong Buy$21.00+79.18%Maintains
2 months ago
Tarsus Pharmaceuticals IncTARS
2Hold$30.00-8.68%Maintains
2 months ago
Day One Biopharmaceuticals IncDAWN
4Strong Buy$44.00+179.37%Maintains
2 months ago
Kodiak Sciences IncKOD
1Strong Sell$2.00-42.36%Reinstates
4 months ago
Immunogen IncIMGN
1Hold$17.00-45.57%Initiates Coverage On
5 months ago
Krystal Biotech IncKRYS
1Strong Buy$160.00-2.42%Initiates Coverage On
5 months ago
Abcellera Biologics IncABCL
2Strong Buy$24.00+513.81%Maintains
8 months ago
Insmed IncINSM
2Strong Buy$39.00N/AMaintains
a year ago
Fate Therapeutics IncFATE
2Strong Sell$4.00N/AMaintains
a year ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$375.00N/AMaintains
a year ago
Verve Therapeutics IncVERV
1Strong Sell$13.00N/AInitiates Coverage On
a year ago
Codiak Biosciences IncCDAKQ
3Hold$1.40N/AMaintains
a year ago
Relmada Therapeutics IncRLMD
2Hold$8.00N/ADowngrades
2 years ago
Vor Biopharma IncVOR
1Hold$6.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.